Kriaar Medent Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 8 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 190.87%
- Profit Growth 304.85%
- Ebitda -928.73%
- Net Worth 18.20%
- Total Assets 60.14%
About Kriaar Medent
Kriaar Medent Private Limited (KMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 June 2016 (Eight years and eight months 5 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Vashi and Sejal Vashi serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2016PTC282007
-
Company No.
282007
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Jun 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kriaar Medent?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Vashi
|
Director | 03-Jun-2016 | Current |
|
Sejal Vashi
|
Director | 03-Jun-2016 | Current |
Financial Performance of Kriaar Medent.
Kriaar Medent Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 190.87% increase. The company also saw a substantial improvement in profitability, with a 304.85% increase in profit. The company's net worth Soared by an impressive increase of 18.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kriaar Medent?
Unlock access to Kriaar Medent's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Horizon Cleford Private LimitedVishal Vashi and Sejal Vashi are mutual person
-
Glaze Dental Depo Private LimitedVishal Vashi and Sejal Vashi are mutual person
-
M3 Packaging LlpVishal Vashi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kriaar Medent?
Unlock and access historical data on people associated with Kriaar Medent, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kriaar Medent, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kriaar Medent's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.